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Smallanthus sonchifolius (yacon), a native plant of South America, was observed to improve lipid profile in rodents and humans.
This study aimed to investigate the antiobesity properties of yacon roots in a high-fat-diet (HFD) model and the underlying
mechanisms. A total of 30Wistar male rats were divided into five groups (n � 6): the standard chow diet (SD) group was fed a SD;
the HFD group was fed a HFD; and the HFD Y340 and HFD Y680 groups were fed a HFD plus yacon flour (340 and 680mg
FOS/kg b. w./day, respectively). HFD Y340 and HFD Y680 rats exhibited marked attenuation of weight gain, a decrease in visceral
fat pad weight, a restoration of the serum lipid profile and atherogenic index in a dose-dependent manner, being the higher dose
more effective (p< 0.05). In addition, we found that HFD Y680 rats showed lower glucose and insulin levels, improved glucose
tolerance, and insulin sensitivity (p< 0.5). A downregulation of several adipocyte specific-transcription factors, including
peroxisome proliferator-activated receptor gamma2 (PPAR-c2), CCAAT/enhancer binding protein a (C/EBP-a) and activating
protein (aP2) mRNA levels, was determined in the visceral adipose tissue of HFD Y680 rats (p< 0.05). An improvement of
adipokine profile in HFD Y680 rats and decreased serum proinflammatory cytokine levels (p< 0.05) were determined by ELISA.
Decreased macrophage infiltration and F4/80 and MCP-1 expression in the visceral adipose tissue of HFD Y680 rats (p< 0.5),
together with a higher pAkt/Akt expression (p< 0.05) were also observed by immunofluorescence and immunoblotting. A
significant increase in glucagon (Gcg) and PYYmRNA levels in distal ileum of HFD Y680 rats (p< 0.05) were also detected. In the
second approach, we determined that yacon supplementation potentiates the effects of the HFD reversion to a standard diet. In
conclusion, yacon showed antiobesity properties by inhibiting adipogenesis and improving the visceral adipose tissue function.
1. Introduction
Overweight and obesity have become a global health problem
owing to their strong association with a high incidence of
various chronic diseases, such as type-2 diabetes, hyperten-
sion, coronary heart disease, and other noncommunicable
diseases [1]. Obesity results from an energy imbalance be-
tween calorie intake and energy expenditure.The extra energy
is stored as triglyceride in adipose tissue through an adipo-
genic process and accumulated in ectopic sites likemuscle and
liver, leading to a metabolic dysfunction [2, 3].
Adipogenesis is a process of cell differentiation by which
precursor mesenchymal cells give rise to mature adipose
cells to fulfill a key metabolic and endocrine role. Different
hormones, nutrients, and transcription factors have been
shown to regulate lipid accumulation during adipocyte
differentiation [4]. Furthermore, the regulation of adipo-
genic transcriptional factors of mRNA levels, such as per-
oxisome proliferator-activator receptor-c (PPAR-c),
CCAAT/enhancer binding protein-α (C/EBP-α), and re-
lated genes (adipocyte fatty acid-binding protein: AP2; fatty
acid synthase: FAS), leads to changes in the activity of key
proteins involved in lipids and fatty acids metabolism, in-
flammation, and cell-cycle regulation [5].
During obesity, adipose tissue expansion is marked not
only by an increase in white adipose tissue mass but also by
morphological changes which affects adipocyte function
[6, 7]. Increasing evidence indicates that the excessive fat
depots, particularly visceral adiposity, are linked to a chronic
low-grade inflammatory state [1, 4, 5]. Moreover, through
the release of free fatty acids (FFAs) and various adipokines
such as leptin, adiponectin, resistin, PAI-1, Il-1b, and TNF-
α, the hypertrophic adipocytes play a role in the progression
of insulin resistance [2, 8].
It is known that obesity is not always spontaneously
reversible, so its treatment requires a multidisciplinary
approach [9]. The combination of diet and physical activity
is only effective during time in which it is practiced and the
available drugs are only moderately effective and have sig-
nificant adverse effects [10, 11]. Dietary supplements have
been proposed to promote weight loss or appetite sup-
pression in the management of obesity. In this sense, natural
products provide a rich source for safe and effective ther-
apeutic compounds with multiple mechanisms of action
[12, 13].
Yacon (Smallanthus sonchifolius (Poepp and Endl.) H.
Robinson) belongs to a member of Asteraceae family, which
ranges through the Andean region in South America
[14, 15]. Yacon roots have special features which include
high water content and large amount of soluble dietary fi-
bers, with low energy density [14]. Given their high content
in fructooligosaccharides (FOSs) [16, 17] and phenolic
compounds, such as chlorogenic and caffeic acids [18],
yacon roots have been considered as a beneficial functional
food with prebiotic properties [19–22]. FOSs are fructose
oligosaccharide joined by β (2 → 1) or β (2 → 6) linkages,
able to resist the hydrolysis of enzymes in the upper gas-
trointestinal tract. Experimental studies have demonstrated
that the addition of oligofructose to the diet improves the
growth of Bifidus and Lactobacillus in the colon enhancing
mineral absorption and gastrointestinal metabolism in both
humans and animals [16, 19]. Dietary polyphenols also
modulated the growth of beneficial microbial populations,
influencing the intestinal mucosa integrity and energy
harvest, through endocrine and systemic metabolic signaling
[23, 24].
Previous studies demonstrated that dietary yacon sup-
plementation reduces postprandial serum triglycerides in
normal rats, without toxicity or adverse nutritional effects
[17]. Also, it was shown that yacon improves beta cell
function and modulates the plasma insulin concentration in
diabetic rats [25, 26]. Additionally, yacon roots present
strong antioxidant activity and anti-inflammatory effects
preventing the risks associated with metabolic diseases
[27–29]. Recently, long-term consumption of yacon syrup
has been shown to improve insulin resistance and reduce
body weight in premenopausal women [30]. These findings
raise the interesting possibility that adipose tissue could be
a target organ of the yacon roots in the management of
obesity. However, no data are currently available on the
ability of yacon roots to affect adipose tissue.
A number of studies have shown that the diet-induced
obese animal models mimic human obesity more than other
models such as genetic knockout mutants [31]. For instance,
rodents chronically exposed to a high-fat diet develop
dyslipidemia, white adipose tissue expansion, insulin re-
sistance, and altered metabolic regulatory hormones [32, 33]
constituting a useful tool to evaluate the potential mecha-
nisms underlying the effects of yacon on obesity.
The current study was designed to assess efficacy of
Smallanthus sonchifolius roots in suppressing visceral fat
accumulation, ameliorate obesity-related phenotypic and
biochemical markers, and provide a molecular mechanism
for how yacon dietary supplementation can improve obesity
in a HFD-fed-rat model. Even more is investigated if the
effects of yacon are modified by the type of diet consumed.
2. Materials and Methods
2.1. Plant Material and Root Flour Preparation. The Small-
anthus sonchifolius (yacon) (Clone LIEY97-1) roots, are
cultivated locally at 550m above the sea level, in the province
of Tucumán, 27S, NW Argentina. Voucher specimens were
deposited in the herbarium of “Instituto Miguel Lillo,” San
Miguel de Tucumán, Tucumán, Argentina (No. 600982LIL).
The roots were carefully washed, peeled, sliced, and dried at
60°C in a forced air circulation oven to reduce water content.
The dried material was then pulverized to obtain yacon roots
flour. The powder was stored at 4°C until use.
2.2. Carbohydrate Composition and Phenolic Content of
Yacon Flour. Total sugar content and carbohydrate com-
position of yacon flour were estimated in samples extracted
with 80% ethanol at 80°C [34]. Total sugar content of yacon
flour was estimated by the phenol-sulphuric acid method
[35]. The extract was dried, dissolved in water, and desalted
with a mixed exchange resin (Amberlite MB3, Sigma). The
purified water extract was injected into an HPLC system
equipped with an IR detector (Gilson 132 IR) using a RSO-
oligosaccharide Ag++ column (Rezex) and water at 70°C as
the mobile phase. Oligosaccharides peaks were identified
using sucrose, glucose, fructose, and fructofuranosylnystose
as external standards [25]. In the experimental designs, daily
intake levels of yacon root flour were calculated with respect
to the amount of FOS using doses equivalent to 340mg
FOS/Kg b. w./day [25] and 680mg FOS/Kg b. w./day cor-
responding to 0.79 and 1.57 g of yacon flour/kg body
weight/day, respectively.
Total polyphenol content was determined by the
Folin–Ciocalteu method [36] and expressed as milligram
gallic acid (GAE) equivalents per gram of flour. Results of
the analysis for the yacon flour are shown in Table 1.
Table 1: Chemical characterization of yacon flour.
Component Content
Total sugar (mg/g flour) 780.0 ± 5.24
FOS (mg/g flour) 432.1 ± 2.17
Sucrose (mg/g flour) 73.3 ± 0.78
Glucose (mg/g flour) 79.6 ± 1.13
Fructose (mg/g flour) 195 ± 0.22
Total polyphenols (mg GAE/g flour) 17.02 ± 3.18
Values are presented as means ± DE (n � 3). GAE, gallic acid.
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2.3.AnimalsandDiets. MaleWistar rats weighing 200–250 g
were obtained from the colony bred at the INSIBIO
(CONICET-UNT), Tucumán, Argentina. Rats were kept in
a breeding room with controlled environment (temperature:
23 ± 1°C, relative humidity: 60 ± 5%, and 12 h light-dark
cycle). All the experimental procedures were in strict ac-
cordance with the Guide for the Care and Use of Laboratory
Animals (Institute of Laboratory Animal Resources, Com-
mission on Life Sciences, National Research Council, Na-
tional Academy Press, Washington, DC) and the local
Animal Care Committee from the Universidad Nacional de
Tucumán (Prot. No. 004/2017).
The experimental animals were randomly divided into
two groups: the standard diet group (SD, n � 12) and the
high-fat-diet group (HFD, n � 36). The SD group was fed ad
libitum, with a standard chow diet containing 12.08 kJ/g
calories: 69.5% from carbohydrates, 5.6% from fat, and
24.9% from protein (Association de Cooperativas
Argentinas-S.E.N.A.S.A. No. 04-288/A). The HFD group
received a standard-based diet enriched with eatable lard
and carbohydrates (modified from [33]) to induce obesity
and hyperlipidemia. The total calories in fat diet were
17.40 kJ/g: 35.0% from carbohydrates, 41.0% from fat, and
24.0% from protein. Both animal groups weremaintained on
each diet for 12 weeks. At this time, animals fed HFD
reached obesity status (Figure 1).
2.4. Experimental Design
2.4.1. Experiment 1. After 12 weeks on HFD or standard
chow, the animals were randomly divided into the following
groups according to the treatment with or without the
addition of yacon flour as a dietary supplement for 8 weeks
(Figure 1).
(i) HFD Y340 group (n � 6), rats fed a high-fat-diet
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Figure 1: Experimental design. (a) Experiment 1: effects of the yacon flour on HFD-induced metabolic disease. (b) Experiment 2: effects of
yacon supplementation and the reversion to a SD diet on HFD-inducedmetabolic disease. SD: standard diet-fed rats; HFD: high-fat-diet-fed
rats; HFD SD: high-fat-diet-fed rats reversed to a SD diet; HFD SY680: high-fat-diet-fed rats reversed to a SD diet and supplemented with
yacon flour (680mg FOS/kg b.z.).
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(ii) HFD Y680 group (n � 6), rats fed a high-fat-diet
plus a tablet of yacon flour equivalent to 680mg
FOS/kg b. w.
(iii) HFD group (n � 6), rats fed a high-fat-diet.
(iv) SD group (n � 6), rats fed standard diet.
2.4.2. Experiment 2. In a second design, after 12 weeks rats
which fed standard diet continued with the same chow,
while animals under HFD were changed to a standard diet
with or without yacon, according to the following scheme
(Figure 1).
(i) HFD SD group (n � 6), rats which change high-fat-
diet feeding by standard diet
(ii) HFD SY group (n � 6) rats which change high-fat-
diet feeding by fed standard diet plus a tablet of
yacon flour containing 680mg FOS/kg b. w.
(iii) HFD group (n � 6), rats fed a high-fat-diet.
(iv) SD group (n � 6), rats fed standard diet.
2.5. Morphometric and Nutritional Determinations.
Animals were weighed (g) weekly throughout the experi-
mental period. Food intakes were recorded daily as follows:
food intake� initial food weight (g) – leftover food weight
(g) – spilled food weight (g); energy intake � food intake (g)
x total energy of the chow diet (kJ/g). The spilled food was
weighed and dried after feces had been picked out. The body
length (nose–anus length), thoracic circumference (imme-
diately behind the foreleg), and abdominal circumference
(immediately anterior to the forefoot) were determined in all
rats at as was described previously [37].The body weight and
body length were used to determine the following anthro-
pometrical parameters: Body mass index (BMI) � body
weight (g)/length2 (cm2); Lee index � cube root of body
weight (g)/nose-to-anus length (cm).
Nutritional parameters were calculated based on food
and caloric intake: energy intake (kJ/day) � mean food
consumption x dietary metabolizable energy; FER (food
efficiency ratio) � (body weight gain/food intake) ×100.
2.6. Tissue Sampling. At the end of the experimental period,
rats were fasted overnight and deeply anaesthetized with 1 :1
xylazin-ketamine. Blood samples were collected by cardiac
puncture into EDTA-Na 4.1%-containing tubes, and plasma
was separated by centrifugation at 3000 g for 10min [25].
Blood samples were collected into plane glass tubes. After
clotting, samples were centrifuged and serum was used for
biochemical determinations. Liver, muscle (soleus), spleen,
pancreas, and visceral (mesenteric), perirenal, and epididymal
fat pads were removed and rinsed thoroughly with ice-cold
saline, blotted, weighed, and fixed in 4% formaldehyde saline
for histological analysis. The remaining tissues were frozen
immediately and stored at −80°C until analyzed.
2.7. Biochemical Determinations. Triglycerides and total
cholesterol concentrations were determined by enzymatic
colorimetric methods using available commercial kits
(Wiener lab Group, Argentina). The high-density lipopro-
tein cholesterol (HDLc) was determined after precipitation
of very low-density lipoprotein (VLDL) and low-density
lipoprotein (LDLc) with polyanions (dextran sulphate and
magnesium chloride). LDL-cholesterol concentration was
determined by a two-step homogeneous assay without
precipitation. Free fatty acids were determined using
available commercial kits (ab65341, Abcam, USA).
Circulating tumor necrosis factor-α (TNF-α) (RAB0479),
interleukin-1β (IL-1β) (RAB0277), insulin (RAB0904) (all
from SIGMA Aldrich, St. Louis, MO, USA), leptin
(ab100773), and adiponectin (ab108784) (Abcam, USA) were
performed using commercially available kits according to the
manufacturer′s instructions.
Blood glucose concentrations were measured using
a glucose meter (Roche Diagnostics GmbH, Mannheim,
Germany). The HOMA-IR (Homeostasis model assessment
of insulin resistance) index was calculated as [fasting glucose
(mg/dl) × fasting insulin (ng/ml)/405] to assess insulin
resistance [38].
2.7.1. Oral Glucose Tolerance Test (OGTT). Rats were ad-
ministered orally with 50% D-glucose (2 g/kg body weight)
after a 12 h fast. Blood glucose concentration was measured
with a Glucometer (Accu-Check; Roche Diagnostics,
GmbH, Mannheim, Germany) with blood from tail-tip
bleedings at 0, 15, 30, 60, and 120min. Area under the
curve (AUC) was calculated as changes from 0 to 120min
and expressed in (mg/dl/min).
2.7.2. Insulin Tolerance Test (ITT). Rats were injected in-
traperitoneally with 0.75 IU/kg body weight porcine Insulin
(Betasint, BETA laboratory) after a 4-hour fast. Blood
glucose concentration was measured with a Glucometer
(Accu-Check; Roche Diagnostics, GmbH, Mannheim,
Germany) with blood from tail-tip bleedings at 0, 15, 30, and
60min. The areas under the curve (AUC 0–60min) were
calculated.
2.7.3. Oral Fat-Loading Test. To assess postprandial increase
in triglyceride, oral fat-load tests were performed at the end
of 8week of yacon diet-supplementation. Rats from the HFD
Y680, HFD, and SD groups were fasted for 12 h. The HFD
Y680 group received a single yacon-tablet containing 680mg
FOS/kg body weight. Thirty minutes later with 2.5ml/kg b.
w. of corn oil was given to all groups of animals. Tail blood
samples were taken at 0 h and 1, 2, 3, and 4 hours after oral
chow administration for the triglycerides determination.
AUCs (0–4 h) were calculated in both experiments.
2.8. Histology and Immunohistochemistry. Samples from
fixed visceral fat were dehydrated, embedded in paraffin, and
cut into 4 μm-thick sections at 50 μm intervals. The sections
were stained with hematoxylin and eosin (H&E), mounted
on glass slides, and examined by optical microscopy. Images
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were analyzed using ImageJ software for quantification
(National Institutes of Health, Bethesda, MD).
After, blocked with 10% (w/v) normal goat serum for 1 h,
sections were subjected to immunohistochemical staining
overnight at 4°C with a 1 :100 dilution of a anti MCP-1
polyclonal antibody (Santa Cruz Biotechnology, USA) fol-
lowing by Alexa Fluor 594 antibody (Invitrogen) (1 h, at
room temperature). The sections were mounted in aqueous
mounting medium with antifading agents (Biomeda, Foster,
CA). The specimens were analyzed using an Olympus BX80
fluorescence microscope (Olympus Optical Ltd., Tokyo) and
the ImageJ software. At least 15 nonadjacent microscope
fields were analyzed in each tissue.
2.9. RNA Extraction and PCR and qPCR Amplification.
Total RNA was isolated from visceral adipose and intestine
tissue using the RNeasy Lipid TissueMini Kit (Qiagen, Basel,
Switzerland) and Trizol reagent (Invitrogen), respectively,
according to the manufacturer′s instruction. 0.5 μg RNAwas
reverse transcribed (RT) into first-strand cDNA using
M-MLV Reverse Transcriptase (Promega, USA) and oligo
(dT) primers (Invitrogen, USA). After the RTprocedure, the
resulting cDNAs were used for PCR and qPCR. Gene ex-
pression was evaluated using a Mastercycler personal in-
strument (Eppendorf, Germany) in optimized conditions
and quantified using the QuantiFast SYBR Green Kit
(Qiagen, Hilden, Germany) on a Lightcycler 2.0 instrument
(Roche Diagnostics, Mannheim, Germany) with the fol-
lowing cycle conditions: 95°C for 10 seconds followed by 30
cycles of 95°C for 5 seconds and 57°C for 30 seconds. The
primers used are PPARc2 (AB019561.1) forward primer 5′-
CCCTGGCAAAGCATTTGTAT-3′ and reverse primer 5′-
ACTGGCACCCTTGAAAAATG-3′; C/EBP-a (NM001287
577) forward primer 5′-GGAGGGACTTAGGGAGTTGG-
3′ and reverse primer 5′-GGAAACCTGGCCTGTTGTAA-
3′; aP2 (U75581) forward primer 5′-GGGACCTGGAAAC
TCGTCTC-3′ and reverse primer 5′-CTGACCGGAT-
GACGACCAAG-3′; Gcg (NM012707.2) forward primer
50-CATTCACAGGGCACATTCAC-30 and reverse primer
50-TGACGTTTGGCAATGTTGTT-30; PYY (AB238226.1)
forward primer 50-GTGGACCAGTGGTGAAGACC-30
and reverse primer 50-GGGACATGAACACACACAGC-30;
β-actin (NM007393) forward primer 5′-CCGGCTTCGCG-
GGCGACG-3′ and reverse primer 5′-TCCCGGCCAGC-
CAGGTCC-3′. The results were normalized to β-actin mRNA
levels.
2.10. Western Blotting. Visceral adipose tissues were ho-
mogenized in the whole cell lysis buffer containing 1% NP-
40, 0.1% SDS, 0.5% sodium deoxycholate (SIGMA Aldrich,
USA), 0.1mM EDTA, 2mM PMSF, a Complete Protease
Inhibitor Cocktail (Roche, Germany), and supernatants
were collected. An amount of 25–50mg of protein was
loaded on to 7.5% SDS polyacrylamide gels and transferred
to 0.22/0.45mm a nitrocellulose membrane (Hybond-C
super; Amersham, Buckinghamshire, UK). The membrane
was blocked with 5% (w/v) fat-free milk dissolved in
phosphate buffered saline containing 0.05% (v/v) Tween-20
(TBST). The membrane was incubated at 4°C overnight with
rabbit polyclonal antibody against Akt (1 :100 dilution; Cell
Signaling Technology Inc. Danvers, USA), p-Akt (1 :100
dilution; Cell Signaling Technology Inc. Danvers, USA),
F4/80 (1 :100 dilution; Santa Cruz Biotech, USA), or Actin
(1 : 3000 dilution; SIGMA Aldrich, USA). The washed
membrane was incubated with HRP-conjugated secondary
antibodies at room temperature for 1 h, and then a biotin-
extrAvidin-peroxidase system (SIGMA Aldrich, USA) was
used to determine signals. Band intensities were quantified
by ImageJ software.
2.11. Statistical Analysis. All results are presented as the
mean ± standard deviation and were analyzed with Graph
Pad Prism 6.01 (San Diego, CA, USA). To assess the sig-
nificance of variation, groups were compared by one-way
ANOVA followed by Bonferroni′s multiple comparisons
test. A probability level of p< 0.05 was considered statisti-
cally significant.
3. Results
3.1. Yacon ImprovesMorphometric andFeeding Parameters in
HFD-Fed Rats. Rats fed a high-fat diet greatly increased the
body weight compared to the SD group (p< 0.05). The
average growth rate for rats on the HFD was 19.7 g/week
while rats on a SD-chow were merely 10.2 g/week. At 12
weeks, the body weight of HFD rats resulted around 20%
higher compared with SD-fed rats (p< 0.05) (Figure 2(a)).
Yacon flour supplementation to the HFD rats for the fol-
lowing 8weeks significantly reduced the final body weight in
a dose-dependent manner (p< 0.05) (Figures 2(a) and 2(b)).
An improvement in the morphometric parameters was also
observed in supplemented rats (Supplemental data,
Table S1). Yacon significantly reduced the food intake
leading to a lower energy intake (p< 0.05) (Figures 2(c) and
2(d)). Food efficiency ratio (FER) was also reduced in both
tested doses compared with the HFD group (p< 0.05)
(Figure 2(e)).
3.2. Yacon Improves Lipid Serum Profiles in HFD-Fed Rats.
Fasting triglycerides (TG), low-density lipoprotein (LDLc),
and free fatty acids levels were increased in HFD-fed rats
compared with the SD group, whereas high-density lipo-
proteins (HDLc) were reduced (p< 0.05). Yacon signifi-
cantly reduced triglycerides and free fatty acids
concentrations in both doses tested with a higher effect at
680mg FOS/kg b. w. (p< 0.05), evidencing a dose-
dependent effect on these parameters. No effect on total
cholesterol levels was observed (p> 0.05). Interestingly,
yacon flour significantly decreased LDLc and increased
HDLc values at the dose of 680mg FOS/kg b. w, improving
the TG/HDLc index (p< 0.05) (Table 2).
3.3. Yacon Improves Body Composition of HFD-Fed Rats.
Table 3 shows the effects of yacon flour consumption on
relative organ weights. HFD-fed rats exhibited an increase in
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hepatic mass and a decrease in the cecum and muscle
(p< 0.05). Administration of yacon supplement reduced the
liver mass in HFD rats in both tested doses (p< 0.05). Only
the dose of 680mg FOS/kg b. w. was able to increase sig-
nificantly the cecum weight. There was no alteration in the
soleus weight after yacon supplementation (p> 0.05). No
significant changes were observed for the spleen and pan-
creas in all the studied groups.
Yacon supplementation significantly reduced the total
fat weight in HFD-fed rats at a dose of 680mg FOS/kg b. w.
(p< 0.05). However, only a tendency to decrease was shown
at 340mg FOS/kg b. w. dose. Interestingly, differences in fat
deposition in terms of epididymal, perirenal, and mesenteric
pads, were observed after yacon supplementation. Yacon
considerably reduced visceral pad weight in both doses
tested, with a maximum effect at 680mg FOS/kg b. w.
(p< 0.05) (Table 3). However, epididymal and retroperito-
neal pads deposition decreased only at a higher dose of
680mg FOS/kg b. w. (p< 0.05) (Table 3).These data led us to
believe that visceral fat may be a target of yacon effects.
3.4. Yacon Modulates Adipocyte Size and Gene Expression in
Adipose Tissue. At the cellular level, obesity is characterized
by an increase in the number (hyperplasia) and size of in-
dividual adipocytes that have differentiated from pre-
adipocyte in fat depots [5]. Histological analysis from
visceral adipose tissue sections stained with H&E revealed
that high-fat feeding increased fat deposits and adipocytes
size in the HFD animals. Interestingly, yacon supplement
(680mg FOS/kg b. w.) resulted in reduced fat deposits and
smaller adipocytes in visceral pad, with similar size to those
observed in SD-fed rat (Figures 3(a) and 3(b)).
To analyze if yacon could modulate the expression of
genes involved in adipogenesis in visceral fat, the amount
of PPAR-c2, a major transcription regulator of adipogenic
process, was measured in supplemented HFD-fed rats. The
expressions of PPAR-c2, as well as their downstream
targets, C/EBPa and aP2, were significantly decreased in
HFD Y680-fed rats (p< 0.05) (Figures 3(c)–3(e)). These
data imply a role of yacon on avoiding visceral adipose























































































































































Figure 2: Effect of yacon flour on HFD-fed rats after 8 weeks of supplementation. (a) Time course of body weight in rats fed standard diet
(SD) or high-fat diet (HFD) supplemented or not with yacon flour (340 or 680mg FOS/kg body weight: HFD Y340 and HFD Y680,
respectively). (b) Body weight gain. (c) Food intake. (d) Energy intake. (e) Feed efficiency ratio (FER). Data are mean ± standard deviation
(n � 6/group). ap< 0.05 vs. SD group, bp< 0.05 vs. HFD group, cp< 0.05 vs. HFD Y340 group.
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3.5. YaconReduces Inflammation inVisceral Adipose Tissue of
HFD-Fed Rats. It is known that excessive adipose tissue ex-
pansion leads to adipose macrophage infiltration and meta-
bolic dysfunction contributing to low-grade local and systemic
inflammation [2]. In this way, we analyzed whether yacon
could modulate inflammatory markers in visceral fat and
serum. MCP-1 expression levels and the macrophage bio-
marker F4/80 were significantly elevated in the visceral adipose
tissue of HFD-fed rats compared with SD rats (p< 0.05).
Yacon supplementation reduced the expression of the men-
tioned markers in HFD-fed animals (Figures 4(a)–4(c)). In
accordance with this fact, yacon also reduced the circulating
level of proinflammatory cytokines TNF-α and IL-1β levels in
HFD-fed animals (Figures 4(d) and 4(e)).
Additionally, adiponectin and leptin have been implicated
in adipose tissue dysfunction [6]. Therefore, the effect of
yacon on modulating these adipokine levels in HFD rats was
evaluated. High leptin and low adiponectin levels were ob-
served in HFD-fed (p< 0.05). Yacon supplementation sig-
nificantly decreased the leptin and increased the adiponectin
concentrations in HFD-fed rats, restoring the
leptin/adiponectin ratio (p< 0.05) (Figures 4(f)–4(h)).
3.6. Yacon Improves Metabolic Parameters in HFD-Fed Rats.
Estimation of blood glucose, insulin, and HOMA-IR
index in the experimental groups is depicted in Fig-
ure 5. The results showed that high-fat feeding led to
alterations in glucose homeostasis inducing a significant
increase in the fasting serum glucose and insulin levels,
accompanied by the increased HOMA-IR index
(p< 0.05). Yacon supplementation significantly decreased
fasting glucose and insulin levels resulting in a lower
HOMA-IR index compared with HFD rats (p< 0.05)
(Figures 5(a)–5(c)).
In addition, during OGTT, SD rats increased the blood
glucose level to a maximum, 15min after the oral glucose
loading, and then declined to the basal value (Figure 5(a)).
Whereas, glucose peak in HFD rats was higher at 15min and
remained high over the 120min. Interestingly, yacon sup-
plementation elicited a significant decrease in the blood
glucose level at 15min and beyond when compared with
HFD rats (Figure 5(d)).The AUCwas significantly increased
in the HFD group compared to the SD group (p< 0.05), but
decreased in the yacon-treated group (p< 0.05). Moreover,
the ITT showed that the blood glucose levels after insulin
injection in the SD- and HFD Y680-fed groups were lower
than those in HFD rats (p< 0.05), indicating that yacon
improved glucose tolerance and insulin resistance in HFD
rats (Figure 5(e)).
Changes in protein expression of Akt, the most im-
portant molecule of the insulin signaling in target organs,
were measured using Western blot analysis (Figure 5(f )).
Akt protein expression was similar in the visceral adipose
tissue of all the analyzed groups (p> 0.05). However, while
Akt phosphoryation in the visceral adipose tissue of HFD
rats was lower compared to SD rats (p< 0.05), yacon sup-
plementation increased the phosphoryation levels of this
protein, in HFD rats leading to higher p-Akt/Akt and
pAkt/Insulin ratios (p< 0.05) (Figures 5(g)).
Table 2: Effects of yacon supplement on serum lipid profile of HFD-fed rats.
SD HFD HFD Y340 HFD Y680
Triglyceride (mg/dl) 64.1 ± 5.0 195.8 ± 12.1a 98.5 ± 2.4b 83.0 ± 4.1b
Total cholesterol (mg/dl) 70.2 ± 14.1 86.2 ± 26.0 80.2 ± 32.0 79.1 ± 18.0
HDLc (mg/dl) 48.0 ± 5.1 32.4 ± 10.3a 40.6 ± 14.2 50.3 ± 7.2b
LDLc (mg/dl) 13.6 ± 8.2 44.2 ± 9.5a 27.2 ± 8.1 19.3 ± 6.5b
TG/HDLc index 1.33 ± 0.11 6.09 ± 1.04a 2.47 ± 0.07b 1.67 ± 0.16b,c
Free fatty acid (mmol/l) 0.76 ± 0.11 1.10 ± 0.13a 0.96 ± 0.05b 0.84 ± 0.07b,c
Values are means ± standard deviation (n � 6 rats/group). ap< 0.05 compared to the SD group. bp< 0.05 compared to the HFD group.
Table 3: Effects of yacon supplement on organs weights of HFD-fed rats.
SD HFD HFD Y340 HFD Y680
Total fat pad (% b. w.) 3.40 ± 0.69 6.44 ± 0.67a 5.54 ± 0.53 3.61 ± 0.95b
Epididymal fat pad
(% b. w.) 1.47 ± 0.13 2.18 ± 0.20
a 1.94 ± 0.26 1.42 ± 0.22b
Perirenal fat pad
(% b. w.) 1.06 ± 0.26 2.55 ± 0.37
a 2.15 ± 0.23 1.47 ± 0.31b
Visceral fat pad
(% b. w.) 0.86 ± 0.23 1.71 ± 0.18
a 1.33 ± 0.12b 0.72 ± 0.22b
Muscle (soleus) (% b. w.) 1.35 ± 0.07 0.98 ± 0.20a 1.20 ± 0.19 1.18 ± 0.26
Liver (% b. w.) 2.66 ± 0.13 3.10 ± 0.18a 2.51 ± 0.11b 2.47 ± 0.12b
Spleen (% b. w.) 0.13 ± 0.01 0.12 ± 0.02 0.13 ± 0.01 0.13 ± 0.03
Pancreas (% b. w.) 0.43 ± 0.11 0.43 ± 0.12 0.49 ± 0.02 0.58 ± 0.06
Cecum (% b. w.) 0.23 ± 0.02 0.16 ± 0.02a 0.20 ± 0.03 0.28 ± 0.04b,c
Values are means ± standard deviation (n � 6 rats/group). ap< 0.05 compared to the SD group. bp< 0.05 compared to the HFD group; cp< 0.05 compared to
the HFD Y340 group. Fat pad weights are expressed as the sum of visceral, retroperitoneal, and epididymal weights. b. w., body weight.
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3.7. Yacon Improves Glucagon and PYY mRNA Expression in
HFD-Fed Rats. It is well established that high-fat diet im-
pairs gastrointestinal peptides secretion, implicated in ap-
petite control and insulin release [31]. Then, we assessed
whether yacon effects are related to changes in incretins
expression. The mRNA levels of glucagon (Gcg), the pre-
cursor of glucagon-like peptide-1 (GLP-1) and the peptide
tyrosine tyrosine (PYY) in distal ileum of the HFD-fed rats
were significantly reduced compared to those of the SD-fed
rats (p< 0.05). Dietary supplementation with yacon strongly
increased Gcg and PYY expression of HFD-fed rats, re-
covering the mRNA levels (p< 0.05).The data concerning to
the expression of intestinal peptides are shown in Figure 6.
3.8. Yacon Decreases Serum Triglyceride Levels after Oral Fat-
Loading. Lipid intestinal uptake is a crucial step for obesity
progression and hyperlipidemia. In order to assess whether
the yacon modifies lipid absorption at the intestinal level, we
perform an oral triglyceride loading test. Figure S1 (Sup-
plementary materials) shows the serum triglyceride values of
the different experimental groups after oral oil loading. HFD
rats showed a sharp increment of triglycerides at 30min,
reaching a maximum peak at 1h and then decreasing to
triglyceride baseline value at 4 h. In contrast, the serum
triglycerides curve of HFD Y680 rats did not increase
considerably from the baseline, being similar to that from SD
rats. These data indicate that yacon attenuates diet-induced
obesity in rats by decreasing fat absorption.
3.9. Yacon Improves the Effects of the Reversion to Standard
Diet. To identify whether the yacon supplementation po-
tentiate the effects of the HFD reversion to a standard diet,
we performed a second experimental design. We found that
all of the parameters analyzed were improved after HFD
rats turned to SD feeding for 8 weeks (Supplementary
materials, Table S1). Interestingly, yacon consumption
strongly reduced the final body weight and the body weight
gain in the HFD SY680 group compared to HFD SD only
(Figures 7(a) and 7(b)). Consistently, body and visceral
adipose weight were significantly lower in HFD SY680-fed
rats when compared with all the other groups (Figures 7(c)
and 7(d)). Rats in the HFD SY680 group showed lower food
intake than HFD SD rats, which resulted in a reduced
energy intake and FER (Supplementary materials,
Figure S2). Serum triglyceride levels of HFD SY680 rats
were also significantly reduced when compared to HFD































































































































Figure 3: Effects of yacon flour on the adipose tissue of HFD-fed rats and adipogenesis-related genes. (a) Representative photomicrographs
of visceral adipose tissue sections stained with H&E (original magnification 126X). (b) Adipocytes size in visceral adipose tissue. qPCR
analysis of visceral fat from rats fed standard diet (SD) or high-fat diet (HFD) supplemented or not with yacon flour (680mg FOS/kg body
weight: HFD Y680) after 8 weeks of treatment: PPAR-c2: peroxisome proliferator-activated receptor gamma2 (c); C/EBP-a: CCAA-
T/enhancer-binding protein (d); aP2: activating protein 2 (e). Data were normalized to Actin mRNA and expressed as fold change over the
SD rats. Values are presented as mean ± standard deviation of triplicate qPCR analysis (n � 6/group). ap< 0.05 vs. SD, bp< 0.05 vs. HFD.
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In accordance with this finding, fasting glucose, glucose
tolerance, and insulin resistance were also improved being
the blood glucose concentrations similar to those of the SD
rats during the glucose challenges (Figures 7(f) and 7(g)).
4. Discussion
Nutritional strategies represent alternatives to pharmaceutical
approaches for reducing hyperglycemia and body weight [13].
Thus, the identification of novel foods that promote satiety or
reduce energy density provides an interesting tool in man-
aging obesity and its associated comorbidities [6, 13].
Here, we report an interesting effect of yacon root flour,
a natural product rich in FOS and phenolic compounds, as
a dietary supplement. The addition of yacon flour to a high-
fat diet, at doses of 340 and 680mg FOS/kg b. w./day, was
effective in reducing body weight, in a dose-dependent
manner. This effect was more pronounced when yacon
was accompanied by a standard diet. Moreover, regional fat
depots analysis showed primarily fat loss from the visceral
pads, a known critical factor in reducing overall disease risk,
including type-2 diabetes development [38]. Furthermore, in
vivo effects of yacon roots on lipid metabolism included













































































































































































Figure 4: Effects of yacon flour on inflammatory markers in HFD-fed rats. (a) Representative sections of visceral fat stained with MCP-1
from rats fed standard diet (SD) or high-fat diet (HFD) supplemented or not with yacon flour (680mg FOS/kg body weight: HFD Y680)
(original magnification 126X). (b) Staining score, assigned to each section according to the MCP-1 levels. (c) F4/80 protein expression of in
visceral fat by western blotting. (d, e) Serum TNF-α and IL-1β concentrations determined by ELISA. (f, g) Plasma leptin and adiponectin
concentrations. (h) Leptin/adiponectin ratio. Data are mean ± standard deviation (n � 6/group). ap< 0.05 vs. SD, bp< 0.05 vs. HFD.









































































































































































































Figure 5: Effects of yacon flour on HFD-induced metabolic disease. (a) Fasting glucose concentrations at the end of experiment. (b) Time
course of glycemia in response to oral glucose overload (2 g/kg body weight) at 8 weeks (insert: area under the curve of blood glucose
following glucose overload). (c) Time course of glycemia following a single intraperitoneal (i.p.) injection of insulin (0.75U/kg b. w.) after 8
weeks of yacon supplementation (insert: area under the curve of blood glucose following insulin injection). (d) Fasting plasma insulin
concentrations at the end of experiment. (e) Homeostasis model assessment of insulin resistance (HOMA-IR) index. (f ) Akt and p-Akt
protein expressions in visceral fat by western blotting.The mean value of SD-fed rats was set at 1. (g) p-Akt/Insulin ratio. Data are expressed
as the mean ± standard deviation (n � 6/group). ap< 0.05 vs. SD, bp< 0.05 vs. HFD. SD: standard diet-fed rats; HFD: high-fat-diet-fed rats;
HFD SD: high-fat-diet-fed rats reversed to a SD chow; HFD SY680: high-fat-diet-fed rats reversed to a SD chow and supplemented with
yacon flour (680mg FOS/kg b. w.).
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free fatty acids towards a healthy atherogenic index in HFD-
fed rats, with a higher effect at 680mg FOS/kg b. w.
One of the mechanisms by which the yacon root triggers
weight loss seems to be a decrease in energy intake, given our
observation of a lower food intake after yacon supple-
mentation. Dietary fiber is known to attenuate food intake
through different mechanisms that include the displacement
of certain nutrients in the diet by the fiber; the inhibition of
food absorption in the small intestine; and modification of
satiety hormone response with appetite reduction [39]. It is
well recognized that FOS could also be a fermentable sub-
strate for the colon microbiota, being low polymerization
FOS (DP2-10) the most used by Bifidobacterium spp. and
Lactobacillus spp. [16]. Bifidobacteria have been shown to be
beneficial to the health of the host and to be correlated with
a lean state [40]. Bacterial fermentation of FOS in the cecum
and proximal colon has been shown to produce short chain
fatty acids such as acetate, propionate and butyrate. In
addition, dietary polyphenols directly or indirectly impact
on gut function, decreasing pathogenic bacterial growth and
promoting the production of the microbial short chain fatty
acids by beneficial microbial populations [23]. These car-
boxylic acids, especially butyrate, are also capable of stim-
ulating the L-cells of the intestinal mucosa increasing the
secretion of gut hormones that are involved in appetite
regulation [41]. It has been reported that inulin-type fruc-
tans fermentation increase the production of the anorexi-
genic hormones glucagon-like peptide-1 (GLP-1) and
peptide YY (PYY) in rodents affecting the food intake and
energy expenditure [42, 43]. Consistently, in the present
work, we reported an increased expression of Gcg (the GLP-
1 precursor) and PYY genes in the distal ileum of yacon
supplemented HFD rats. In concordance, increased GLP-1
levels in the colon and in serum were shown when yacon
roots were administered to diabetic rats [25]. Thus, FOS and
phenolic compounds present in yacon flour could be able to
decrease body weight in HFD rats, through the central action
of GLP-1 and PYY.
Chronic consumption of a high-fat diet has been shown
to produce obesity characterized by a separate or simulta-
neous increase in adipocyte number and size [2]. Yacon
roots had a significant effect on the reduction of visceral
adipose tissue mass and adipocyte size. The expansion of
adipose tissue begins when differentiated adipocytes rapidly
respond to nutrient excess acting as lipid-synthesizing and
lipid storing cells [5]. The differentiation of preadipocytes
involves a highly regulated and coordinated cascade of
transcription factors, where PPAR-c and C/EBPa play
a central role [4, 44]. PPAR-c2 is the major regulator of
adipogenesis and is also required for the maintenance of the
adipocyte differentiated state [45]. PPAR-c2, a splicing
isoform of PPAR-c, is selectively expressed in the adipose
tissues. In powerful synergy with C/EBPa, PPAR-c2 controls
adipocyte differentiation and lipid metabolism by regulating
transcription factors such as aP2 and lipogenic/lipolytic
genes and thus enhances the efficiency of lipid utilization
[46, 47]. aP2 is a carrier protein for fatty acids mainly
expressed in adipocytes and macrophages and plays an
important role in the development of insulin resistance and
metaflammation [45]. In our study, the mRNA levels of the
transcription factor PPAR-c2 and its target genes C/EBPa
and aP2 increased in the visceral adipose tissue of the HFD-
fed rats. Similarly, previous reports indicated that PPAR-c2
mediates high-fat-diet-induced adipocyte differentiation
and adipocyte hypertrophy to generate large adipocytes and
insulin resistance in obese patients [48] and in animal
models [49]. Thus, decreased PPAR-c, C/EBPa, and aP2
expression in visceral adipose tissue by yacon supplement
may suppress adipogenesis, enhancing insulin sensitivity,
and lowering blood lipid concentrations. Similarly, it has
been reported that inulin-type fructans have an effect on
differentiation and triglyceride accumulation in adipocytes
through a decrease in PPARc-activated processes [50].
Increased adiposity during obesity greatly influences
insulin sensitivity, glucose and lipid metabolism, and in-
flammation [3, 8, 45]. In the present study, rats long exposed
to high-fat diet developed a hyperglycemic state associated
with insulin resistance and/or glucose intolerance. Adipo-
nectin is the most abundantly adipokine expressed in adi-
pose tissue with pleiotropic insulin-sensitizing effects. It has
been shown that it reduces hepatic glucose production and
stimulates glucose uptake and fatty acid oxidation in skeletal
muscle [51]. Leptin, another adipokine, regulates weight
balance, glucose, and lipids metabolism [52]. While adi-
ponectin levels reduce in response to excessive fat depots,
plasma leptin concentrations are positively associated with
the amount of body fat [53]. In our study, yacon supplement
































































Figure 6: Effects of yacon flour on intestinal mRNA levels of
proglucagon and PYY in HFD-fed rats. Proglucagon: Gcg (a) and
polypeptide YY: Pyy (b) mRNA expression in intestinal samples of
rats fed standard diet (SD) or high-fat diet (HFD) supplemented or
not with yacon flour (680mg FOS/kg body weight: HFD Y680)
after 8 weeks of treatment. Data were normalized to Actin mRNA
and expressed as fold change over the SD rats. Values are presented
as mean ± standard deviation of triplicate PCR analysis
(n � 6/group). ap< 0.05 vs. SD, bp< 0.05 vs. HFD. SD: standard
diet-fed rats; HFD: high-fat-diet-fed rats; HFD SD: high-fat-diet-
fed rats reversed to a SD chow; HFD SY680: high-fat-diet-fed rats
reversed to a SD chow and supplemented with yacon flour (680mg
FOS/kg b. w.).
Journal of Obesity 11























































































































































































































































Figure 7: Effects of yacon supplement and the reversion to a SD chow on HFD-induced metabolic disease. (a) Body weight. (b) Body weight
gain. (c) Total fat weight. (d) Visceral fat pad weight. (e) Fasting triglyceride concentrations. (f ) Time course of glycemia in response to oral
glucose overload (2 g/kg body weight) at 8 weeks (insert: area under the curve of blood glucose following glucose overload). (g) Time course
of glycemia following a single intraperitoneal (i.p.) injection of insulin (0.75U/kg b. w.) (insert: area under the curve of blood glucose
following insulin injection). Data are mean ± standard deviation (n � 6/group). ap< 0.05 vs. SD, bp< 0.05 vs. HFD, cp< 0.05 vs. HFD SD.
SD: standard-diet-fed rats; HFD: high-fat-diet-fed rats; HFD SD: high-fat-diet-fed rats reversed to a SD chow; HFD SY680: high-fat-diet-fed
rats reversed to a SD chow and supplemented with yacon flour (680mg FOS/kg b.w.).
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concentrations increasing adiponectin/leptin ratio.Thus, the
improved glucose tolerance and insulin action in obese rats
after yacon supplementation may lead us to suggest that this
beneficial effect could be mediated by adipokines modula-
tion as was suggested previously [54]. Moreover, releasing
GLP-1 from intestinal L-cells directly into the portal vein
could also represent an additional mechanism related to
yacon FOS-improved glucose homeostasis [55]. On the
other hand, phenolic compounds are been involved in the
regulation of postprandial glycemia and glucose tolerance
also modulating gastrointestinal hormone secretion [56].
Obesity is now considered as a chronic inflammatory
state linked to an abnormal cytokine production and the
activation of inflammatory signaling pathways in adipose
tissue [1, 3, 5]. The excess of nutrients induces the accu-
mulation of macrophages, through the monocyte chemo-
attractant protein-1 (MCP-1), and is implicated in the
development and maintenance of obesity-induced adipose
tissue inflammation [57]. In the present study, we described
an increased expression of MCP-1 and the macrophage
marker F4/80 in the adipose tissue of obese animals which
was significantly reduced by yacon supplement. This allows
us to suggest that inhibition of MCP-1 by yacon supplement
could lead to a low level of macrophage infiltration con-
tributing to reduce adipose tissue inflammation improving
insulin resistance and metabolic state. Moreover, our results
also demonstrated that yacon treatment significantly de-
creased circulating levels of proinflammatory cytokines
TNF-α and IL-1β in HDF-rats. This fact could be related to
lower levels of TNFα, IL-1β, andMCP1 in the adipose tissues
of supplemented HFD rats. Furthermore, it has been
established that inflammatory cytokines TNF-α and IL-6
inhibit the expression of insulin signaling mediators in
adipose tissue leading to a worsening of whole-body insulin
resistance and glucose intolerance [1, 3]. Our results dem-
onstrated that long-term yacon supplementation amelio-
rates abnormal insulin signaling cascades in the visceral
adipose tissue of HFD rats by enhancing the phosphory-
lation level of the Akt protein, the pAkt/Akt ratio, and
pAkt/Insulin ratio. In agreement with this, Satoh et al. [58]
using a euglycemic-hyperinsulinemic clamp procedure
demonstrated that yacon diet improved hepatic insulin
sensitivity by increasing liver Akt activation in Zucker fa/fa
rats.
High-fat diet is considered a direct cause in the devel-
opment of dyslipidemia during obesity [31, 32]. The data
obtained in the present study demonstrated that yacon flour
administered to obese rats improved the lipids profile, re-
ducing triglycerides and LDLc. It is interesting to note that
the beneficial effects in lipids metabolism are more evident
when yacon supplementation is accompanied by a standard
diet. As previously reported by us, yacon roots exhibit a lipid
lowering effect, mainly reducing serum triglycerides and
VLDLc levels, in normal and diabetic rats [17, 25]. More-
over, in human studies, we demonstrate that yacon syrup
lowers plasma lipid concentrations and decreases glycemia
in patients with insulin resistance [30]. The triglyceride
lowering effect could explain at least in part the inhibition of
de novo fatty acid synthesis and downregulation of lipogenic
enzymes as has been suggested for oligofructose [59]. In
addition, it is well known that soluble dietary fibers delay fat
absorption as we observed during the fat load test, con-
tributing to the hypolipidemic effects of yacon.
On the other hand, the lack of significant changes in total
cholesterol levels in our study may be explained by the short
supplement-time and/or the concentration of FOS utilized
in our study. Reductions in cholesterol have only been found
with long-term feeding of oligofructose in relatively high
doses [60]. Additionally, the presence chlorogenic and
caffeic acid in yacon roots could also contribute to the
hypolipidemic effect observed after yacon supplement [18].
It was established that caffeic acid, particularly chlorogenic
acid, improves lipid metabolism in high-fat-diet-induced
obese mice [61].
5. Conclusion
The data presented in this study suggest that yacon may act
by different ways to suppress body weight gain, food intake,
FER levels, weight and size of adipose tissue, and serum
levels of triglyceride and improve adipokine profile in HFD-
fed rats. These results can be associated with the decrease in
adipogenesis related to mRNA expression of PPAR-c,
C/EBPa, and aP2. The high content of nondigestible fer-
mentable fibers present in yacon roots as FOS together with
phenolic compounds could be largely responsible for the
beneficial effects observed. This simple dietary intervention
appears to be capable of improving obesity outcomes re-
gardless of susceptibility to an obesogenic nutritional en-
vironment. Hence, yacon roots can be considered a potent
and useful functional food.
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[52] H. Cui, M. López, and K. Rahmouni, “The cellular and
molecular bases of leptin and ghrelin resistance in obesity,”
Nature Reviews Endocrinology, vol. 13, no. 6, pp. 338–351,
2017.
[53] K. G. Park, K. S. Park, M. J. Kim et al., “Relationship between
serum adiponectin and leptin concentrations and body fat
distribution,” Diabetes Research and Clinical Practice, vol. 63,
no. 2, pp. 135–142, 2004.
[54] M. V. Grande, S. S. Sánchez, and S. M. Honoré, “Dietary
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